Skip to main content
. 2021 Mar 29;111:104862. doi: 10.1016/j.bioorg.2021.104862

Fig. 5.

Fig. 5

The binding poses of the top eight binders. The top eight compounds identified by an enzyme inhibition assay following in silico screening are shown in the order of decreasing inhibitory activity: corilagin (NP), ZINC000011865175 (NP), lurasidone (FDA), telcagepant (INV), cilostazol (FDA), rhoifolin (NP), apixaban (FDA), and dasatinib (FDA). The same protein and ligand representations as in Fig. 3 are used.